Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
23 June 2024
21 June 2024
02:46 | Template:KDRG diffhist +12 Kosar Doraghi talk contribs |
N 02:46 | Rytelo diffhist +10,735 Kosar Doraghi talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D. [mailto:K.doraghi@yahoo.com] |genericName=Imetelstat |aOrAn=an |drugClass=oligonucleotide telomerase inhibitor |indicationType=treatment |indication=oligonucleotide telomerase inhibitor adult patients with low- to intermediate-1 risk myelodysplastic syndromes (MDS) with transfusion-dependent anemia requiring 4 or more red blood cell units over 8 weeks who have not responded to or have lost response to or are...") |
13 June 2024
|
02:33 | Template:KDRG 2 changes history +87 [Kosar Doraghi (2×)] | |||
|
02:33 (cur | prev) +73 Kosar Doraghi talk contribs | ||||
|
02:25 (cur | prev) +14 Kosar Doraghi talk contribs |
02:31 | Xolremdi diffhist +30 Kosar Doraghi talk contribs |
8 June 2024
N 23:02 | Xolremdi diffhist +15,628 Kosar Doraghi talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D. [mailto:k.doraghi@yahoo.com] |genericName=mavorixafor |aOrAn=a |drugClass=CXC chemokine receptor 4 (CXCR4) antagonist |indicationType=treatment |indication=patients 12 years of age and older with WHIM syndrome (warts, hypogammaglobulinemia, infections and myelokathexis) to increase the number of circulating mature neutrophils and lymphocytes. |hasBlackBoxWarning=Yes |adverseReactions=thrombocytopenia, pityr...") |
2 June 2024
1 June 2024
03:21 | Template:KDRG diffhist +15 Kosar Doraghi talk contribs |
N 03:20 | WINREVAIR diffhist +16,566 Kosar Doraghi talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D. [mailto:k.doraghi@yahoo.com] |genericName=sotatercept-csrk |aOrAn=an |drugClass=activin signaling inhibitor |indicationType=treatment |indication=adults with pulmonary arterial hypertension (PAH, WHO Group 1) to increase exercise capacity, improve WHO functional class (FC) and reduce the risk of clinical worsening events |hasBlackBoxWarning=Yes |adverseReactions=headache, epistaxis, rash, telangiect...") |